The frequency of naïve and early-activated hapten-specific B cell subsets dictates the efficacy of a therapeutic vaccine against prescription opioid abuse

Por Laudenbach, Megan, Baruffaldi, Federico, Vervacke, Jeffrey S, Distefano, Mark D, Titcombe, Philip J, Mueller, Daniel L, Tubo, Noah J, Griffith, Thomas S, Pravetoni, Marco
Publicado no J Immunol (2015)

Antibody responses to de novo identified citrullinated fibrinogen peptides in rheumatoid arthritis and visualization of the corresponding B cells

Por Joshua, Vijay, Schobers, Loes, Titcombe, Philip J., Israelsson, Lena, Rönnelid, Johan, Hansson, Monika, Catrina, Anca I., Pruijn, Ger J. M., Malmström, Vivianne
Publicado no Arthritis Res Ther (2016)

Macrophage scavenger receptor 1 (Msr1, SR-A) influences B cell autoimmunity by regulating soluble autoantigen concentration

Por Haasken, Stefanie, Auger, Jennifer L., Taylor, Justin J., Hobday, Patricia M., Goudy, Brian D., Titcombe, Philip J., Mueller, Daniel L., Binstadt, Bryce A.
Publicado em 2013

Deletion and anergy of polyclonal B cells specific for ubiquitous membrane-bound self-antigen

Por Taylor, Justin J., Martinez, Ryan J., Titcombe, Philip J., Barsness, Laura O., Thomas, Stephanie R., Zhang, Na, Katzman, Shoshana D., Jenkins, Marc K., Mueller, Daniel L.
Publicado em 2012